Case 1: Herpes Simplex Virus Infection

Case-Based Modules
Initial Evaluation
Dermatologic Manifestations
Oral Manifestations
OIs: Prophylaxis
OIs: Treatment
Antiretroviral Rx
Antiretroviral Rx: Resistance
Antiretroviral Rx: Adverse Effects
Drug-Drug Interactions
Postexposure Prophylaxis
Perinatal Transmission
Special Populations
Prevention for Positives
Challenging Unknowns
Interactive Tutorials
This program is funded through Health Resources and Services Administration, US Department of Health and Human Services.

Home
About This Site
Free CME
AETC NRC
Resources
Feedback
Site Map
Authors

Question | Discussion | References | CME Credit

You answered:

	The most appropriate therapy for this lesion would be valganciclovir (Valcyte) 900 mg PO bid x 4 weeks.

This answer is incorrect. Valganciclovir (Valcyte) is an antiviral compound with excellent activity against cytomegalovirus and moderate activity against HSV. Ganciclovir is not considered a recommended drug for the treatment of HSV infections.

Choose another answer:

	When performing a fluorescent antibody (FA) and culture for HSV, scraping the base of the lesion will provide a higher yield than obtaining exudative fluid.
	The diagnosis of chronic (longer than 4 weeks) ulcerative herpes simplex is an AIDS-defining condition, regardless of CD4 cell count.
	Answers A and C are correct.

[Back to Case 1 Question | Go to Correct Answer]